STOCK TITAN

[Form 4] CalciMedica, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

CalciMedica, Inc. (CALC) – Form 4 filed 10 Jul 2025

Chief Business Officer, Director and 10% owner Eric W. Roberts reported an open-market purchase of 5,000 common shares on 09 Jul 2025 at $1.6047 per share. After the transaction, he beneficially owns roughly 1,002,410 CALC shares distributed across direct holdings (164,706 shares), several Roth/Traditional IRAs and three Valence Investments SPVs, the largest of which holds 356,989 shares. No derivative securities were transacted in this filing.

The acquisition marginally increases Roberts’ stake by about 0.5% and may signal incremental confidence, though the dollar value is modest relative to his existing position.

CalciMedica, Inc. (CALC) – Modulo 4 depositato il 10 luglio 2025

Eric W. Roberts, Chief Business Officer, Direttore e proprietario del 10%, ha comunicato un acquisto sul mercato aperto di 5.000 azioni ordinarie il 9 luglio 2025 al prezzo di $1,6047 per azione. Dopo la transazione, detiene beneficiariamente circa 1.002.410 azioni CALC distribuite tra partecipazioni dirette (164.706 azioni), diversi Roth/Traditional IRA e tre SPV di Valence Investments, la più grande delle quali possiede 356.989 azioni. Non sono stati effettuati scambi di strumenti derivati in questa comunicazione.

L'acquisizione aumenta marginalmente la quota di Roberts di circa lo 0,5% e potrebbe indicare una maggiore fiducia, anche se il valore in dollari è modesto rispetto alla sua posizione attuale.

CalciMedica, Inc. (CALC) – Formulario 4 presentado el 10 de julio de 2025

Eric W. Roberts, Director Comercial, Director y propietario del 10%, reportó una compra en el mercado abierto de 5,000 acciones comunes el 9 de julio de 2025 a $1.6047 por acción. Tras la transacción, posee beneficiariamente aproximadamente 1,002,410 acciones de CALC distribuidas entre tenencias directas (164,706 acciones), varias cuentas Roth/Traditional IRA y tres vehículos SPV de Valence Investments, siendo el mayor de ellos con 356,989 acciones. No se realizaron transacciones con valores derivados en esta presentación.

La adquisición incrementa ligeramente la participación de Roberts en alrededor del 0.5% y podría indicar una confianza creciente, aunque el valor en dólares es modesto en relación con su posición actual.

CalciMedica, Inc. (CALC) – 2025년 7월 10일 제출된 Form 4

최고사업책임자(CBO), 이사 및 10% 지분 보유자인 Eric W. Roberts2025년 7월 9일 주당 $1.6047에 5,000주 보통주를 공개 시장에서 매수했다고 보고했습니다. 거래 후 그는 직접 보유(164,706주), 여러 Roth/Traditional IRA 계좌 및 세 개의 Valence Investments SPV에 분산된 약 1,002,410주 CALC 주식을 실질적으로 소유하고 있습니다. 이번 신고에서는 파생상품 거래는 없었습니다.

이번 매수는 Roberts의 지분을 약 0.5% 가량 소폭 증가시켰으며, 기존 보유량에 비해 금액은 크지 않지만 신뢰가 조금 더 높아졌음을 시사할 수 있습니다.

CalciMedica, Inc. (CALC) – Formulaire 4 déposé le 10 juillet 2025

Eric W. Roberts, Chief Business Officer, administrateur et détenteur de 10%, a déclaré un achat sur le marché libre de 5 000 actions ordinaires le 9 juillet 2025 au prix de 1,6047 $ par action. Après cette transaction, il détient bénévolement environ 1 002 410 actions CALC, réparties entre des participations directes (164 706 actions), plusieurs comptes Roth/Traditional IRA et trois véhicules SPV de Valence Investments, dont le plus important détient 356 989 actions. Aucune opération sur titres dérivés n’a été réalisée dans ce dépôt.

Cette acquisition augmente légèrement la participation de Roberts d’environ 0,5 % et pourrait indiquer une confiance accrue, bien que la valeur en dollars soit modeste par rapport à sa position actuelle.

CalciMedica, Inc. (CALC) – Formular 4 eingereicht am 10. Juli 2025

Chief Business Officer, Direktor und 10%-Eigentümer Eric W. Roberts meldete einen Offenmarkt-Kauf von 5.000 Stammaktien am 09. Juli 2025 zu je $1,6047. Nach der Transaktion besitzt er wirtschaftlich etwa 1.002.410 CALC-Aktien, verteilt auf direkte Beteiligungen (164.706 Aktien), mehrere Roth/Traditional IRAs und drei Valence Investments SPVs, von denen das größte 356.989 Aktien hält. Keine Derivatgeschäfte wurden in dieser Meldung getätigt.

Der Erwerb erhöht Roberts' Anteil geringfügig um etwa 0,5% und könnte auf ein wachsendes Vertrauen hindeuten, obwohl der Dollarwert im Verhältnis zu seiner bestehenden Position moderat ist.

Positive
  • Insider purchase: 5,000 CALC shares bought on 07/09/2025 at $1.6047, indicating continued executive confidence.
  • Large existing stake: Post-transaction beneficial ownership totals about 1,002,410 shares, aligning executive incentives with shareholders.
  • No sales or derivative exercises reported, removing immediate dilution or profit-taking concerns.
Negative
  • Immaterial size: The 5,000-share buy equals roughly 0.5% of Roberts’ holdings and less than $9 k in value, limiting signaling power.
  • Single-participant action: No concurrent insider purchases by other executives were disclosed, reducing breadth of bullish signal.

Insights

TL;DR: Modest insider buy; confidence signal limited by small size.

Roberts’ 5,000-share purchase confirms continued alignment between management and shareholders, yet represents only ~0.5% of his 1.0 million-share stake. Absence of selling and lack of derivative activity keep the filing neutral-to-slightly positive, but the low transaction value (<$9 k) is unlikely to alter market perception or near-term valuation. Overall impact: limited.

CalciMedica, Inc. (CALC) – Modulo 4 depositato il 10 luglio 2025

Eric W. Roberts, Chief Business Officer, Direttore e proprietario del 10%, ha comunicato un acquisto sul mercato aperto di 5.000 azioni ordinarie il 9 luglio 2025 al prezzo di $1,6047 per azione. Dopo la transazione, detiene beneficiariamente circa 1.002.410 azioni CALC distribuite tra partecipazioni dirette (164.706 azioni), diversi Roth/Traditional IRA e tre SPV di Valence Investments, la più grande delle quali possiede 356.989 azioni. Non sono stati effettuati scambi di strumenti derivati in questa comunicazione.

L'acquisizione aumenta marginalmente la quota di Roberts di circa lo 0,5% e potrebbe indicare una maggiore fiducia, anche se il valore in dollari è modesto rispetto alla sua posizione attuale.

CalciMedica, Inc. (CALC) – Formulario 4 presentado el 10 de julio de 2025

Eric W. Roberts, Director Comercial, Director y propietario del 10%, reportó una compra en el mercado abierto de 5,000 acciones comunes el 9 de julio de 2025 a $1.6047 por acción. Tras la transacción, posee beneficiariamente aproximadamente 1,002,410 acciones de CALC distribuidas entre tenencias directas (164,706 acciones), varias cuentas Roth/Traditional IRA y tres vehículos SPV de Valence Investments, siendo el mayor de ellos con 356,989 acciones. No se realizaron transacciones con valores derivados en esta presentación.

La adquisición incrementa ligeramente la participación de Roberts en alrededor del 0.5% y podría indicar una confianza creciente, aunque el valor en dólares es modesto en relación con su posición actual.

CalciMedica, Inc. (CALC) – 2025년 7월 10일 제출된 Form 4

최고사업책임자(CBO), 이사 및 10% 지분 보유자인 Eric W. Roberts2025년 7월 9일 주당 $1.6047에 5,000주 보통주를 공개 시장에서 매수했다고 보고했습니다. 거래 후 그는 직접 보유(164,706주), 여러 Roth/Traditional IRA 계좌 및 세 개의 Valence Investments SPV에 분산된 약 1,002,410주 CALC 주식을 실질적으로 소유하고 있습니다. 이번 신고에서는 파생상품 거래는 없었습니다.

이번 매수는 Roberts의 지분을 약 0.5% 가량 소폭 증가시켰으며, 기존 보유량에 비해 금액은 크지 않지만 신뢰가 조금 더 높아졌음을 시사할 수 있습니다.

CalciMedica, Inc. (CALC) – Formulaire 4 déposé le 10 juillet 2025

Eric W. Roberts, Chief Business Officer, administrateur et détenteur de 10%, a déclaré un achat sur le marché libre de 5 000 actions ordinaires le 9 juillet 2025 au prix de 1,6047 $ par action. Après cette transaction, il détient bénévolement environ 1 002 410 actions CALC, réparties entre des participations directes (164 706 actions), plusieurs comptes Roth/Traditional IRA et trois véhicules SPV de Valence Investments, dont le plus important détient 356 989 actions. Aucune opération sur titres dérivés n’a été réalisée dans ce dépôt.

Cette acquisition augmente légèrement la participation de Roberts d’environ 0,5 % et pourrait indiquer une confiance accrue, bien que la valeur en dollars soit modeste par rapport à sa position actuelle.

CalciMedica, Inc. (CALC) – Formular 4 eingereicht am 10. Juli 2025

Chief Business Officer, Direktor und 10%-Eigentümer Eric W. Roberts meldete einen Offenmarkt-Kauf von 5.000 Stammaktien am 09. Juli 2025 zu je $1,6047. Nach der Transaktion besitzt er wirtschaftlich etwa 1.002.410 CALC-Aktien, verteilt auf direkte Beteiligungen (164.706 Aktien), mehrere Roth/Traditional IRAs und drei Valence Investments SPVs, von denen das größte 356.989 Aktien hält. Keine Derivatgeschäfte wurden in dieser Meldung getätigt.

Der Erwerb erhöht Roberts' Anteil geringfügig um etwa 0,5% und könnte auf ein wachsendes Vertrauen hindeuten, obwohl der Dollarwert im Verhältnis zu seiner bestehenden Position moderat ist.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Roberts Eric W

(Last) (First) (Middle)
C/O CALCIMEDICA, INC.
505 COAST BLVD. S. #307

(Street)
LA JOLLA CA 92037

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CalciMedica, Inc. [ CALC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
CHIEF BUSINESS OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
07/09/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/09/2025 P 5,000 A $1.6047 37,823 I By FMTC Custodian - Roth IRA FBO Eric W. Roberts
Common Stock 164,706 D
Common Stock 49,894 I By Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA
Common Stock 10,661 I By IRA Financial Trust Company CFBO Eric W. Roberts
Common Stock 356,989 I By Valence Investments SPV IV, LLC
Common Stock 66,228 I By Valence Investments SPV V, LLC
Common Stock 316,109 I By Valence Investments SPV VI, LLC
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ John Dunn, Esq., Attorney-in-Fact 07/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many CALC shares did Eric W. Roberts purchase on July 9, 2025?

He bought 5,000 shares of CalciMedica common stock.

What price did the insider pay per CALC share?

The shares were acquired at an average price of $1.6047.

What is Eric W. Roberts’ total beneficial ownership after the transaction?

Roberts now beneficially owns approximately 1,002,410 CALC shares across direct and indirect accounts.

Were any derivative securities involved in this Form 4 filing?

No. No derivative securities were acquired, disposed of, or held in this report.

What roles does Eric W. Roberts hold at CalciMedica (CALC)?

He is a Director, 10% Owner and Chief Business Officer of the company.
CALCIMEDICA INC

NASDAQ:CALC

CALC Rankings

CALC Latest News

CALC Latest SEC Filings

CALC Stock Data

22.49M
11.67M
17.6%
52.45%
0.72%
Biotechnology
Pharmaceutical Preparations
Link
United States
LA JOLLA